Walleye Trading LLC Vanda Pharmaceuticals Inc. Call Options Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	SELL	$9.31 - $11.84 $62,377 - $79,328	-6,700 Reduced 50.38%	6,600 $72,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $73,712 - $112,540	-6,800 Reduced 33.83%	13,300 $150,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $62,760 - $84,560	4,000 Added 24.84%	20,100 $315,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $247,135 - $342,447	16,100 New	16,100 $276,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $39,750 - $89,040	-5,300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $65,614 - $92,591	5,300 New	5,300 $87,000
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $218,116 - $385,020	-12,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $117,614 - $195,114	6,200 Added 100.0%	12,400 $324,000
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $113,150 - $142,600	6,200 New	6,200 $142,000
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $526,875 - $757,500	-37,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $481,875 - $678,750	37,500	37,500 $569,000

155

43.7M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $290M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.